Wen Jin

Dr. Wen Jin

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
YXYan Xiong
Yan Xiong
ZWZihuan Wu
Zihuan Wu
BZBin Zhang
Bin Zhang
CWChao Wang
Chao Wang
FMFengyi Mao
Fengyi Mao
SKShihuan Kuang
Shihuan Kuang
Fibronectin type III domain containing 5 (Fndc5) is a transmembrane protein highly expressed in the skeletal muscle. It was reported that exercise promotes the shedding of the extracellular domain of Fndc5, generating a circulating peptide (irisin) that cross‐talks to adipose tissues to convert lipid‐storing white adipocytes to energy‐catabolizing beige adipocytes. However, the requirement of Fndc5 in mediating the beneficial effect of exercise remains to be determined. Here, we created a mouse model of Fndc5 mutation through transcription activator–like effector nuclease–mediated DNA targeting. The Fndc5 mutant mice have normal skeletal muscle development, growth, regeneration, as well as glucose and lipid metabolism at resting state, even when fed a high‐fat diet. In response to running exercise, however, the Fndc5 mutant mice exhibit reduced glucose tolerance and insulin sensitivity and have lower maximal oxygen consumption compared with the exercised wild‐type mice. Mechanistically, Fndc5 mutation attenuates exercise‐induced browning of white adipose tissue that is crucial for the metabolic benefits of physical activities. These data provide genetic evidence that Fndc5 is dispensable for muscle development and basal metabolism but essential for exercise‐induced browning of white adipose tissues in mice.—Xiong, Y., Wu, Z., Zhang, B., Wang, C., Mao, F., Liu, X., Hu, K., Sun, X., Jin, W., Kuang, S. Fndc5 loss‐of‐function attenuates exercise‐induced browning of white adipose tissue in mice. FASEB J. 33, 5876–5886 (2019). www.fasebj.org

13 October 2014 in Molecules
Verified
Journal Article
Open access
PDF file
QLQiu-Yue Li
Qiu-Yue Li
KLKai-Tong Li
Kai-Tong Li
HSHong Sun
Hong Sun
WJWen Jin
Wen Jin
JSJia-Wen Shi
Jia-Wen Shi
YSYue Shi
Yue Shi
A rapid, sensitive and selective liquid chromatography/tandem mass spectrometry method (LC-MS/MS) was developed and validated for determination of dehydrocorydaline (DHC) in rat plasma using nitidine chloride as an internal standard. The analytes were solid-phase extracted and eluted on a C18 chromatography column using a mobile phase of acetonitrile and water (containing 0.8% formic acid and 10 mM ammonium acetate) (28:72, v/v). Detection was performed using positive ion electrospray ionization in multiple reaction monitoring modes. The assay was linear over the concentration range 0.625–250 ng/mL with a quantification limit of 0.625 ng/mL. The precision was 93.1%, and extraction recovery ranged from 92.1% to 107%. The validated method was successfully applied to the pharmacokinetics and excretion study of DHC in rat plasma after oral administration of pure DHC and an effective fraction of Corydalis yanhusuo (EFY). The pharmacokinetic parameters showed that DHC from EFY was absorbed more rapidly and eliminated more slowly than pure DHC. The result suggests that the differences might be due to the presence of P-glycoprotein (P-gp) inhibitors and that other alkaloids co-existing in the EFY may compete with DHC for transportation by P-gp, metabolization by P450, and binding to plasma proteins.

6 November 2025 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
XLXiaoya Li
Xiaoya Li
MFMeirong Fang
Meirong Fang
XLXingyu Liu
Xingyu Liu
JJJingyi Jiang
Jingyi Jiang
SWShengchen Wang
Shengchen Wang
WJWen Jin
Wen Jin
Diabetes mellitus, a metabolic disorder of rising global incidence, imposes substantial health burdens through its systemic complications. Although the treatment strategies based on pathological changes and molecular mechanisms are constantly upgrading, the therapeutic effects, especially for complications, are not satisfactory. Emerging evidence highlights ferroptosis—an iron-dependent cell death pathway—as a critical regulator in diabetic pathophysiology. This review synthesizes clinical data, genetic studies, and therapeutic interventions across experimental models to establish ferroptosis’s multifaceted involvement in diabetes progression. Multiorgan analyses (pancreatic islets, heart, kidney, liver, brain, etc.) reveal ferroptosis-mediated pathways connecting localized tissue damage to systemic diabetic pathogenesis. Particularly, ferroptosis intersects with characteristic diabetic mechanisms, including oxidative stress, lipid peroxidation, and mitochondrial dysfunction. Our integrated assessment positions ferroptosis as a converging pathological mechanism in diabetes, proposing its molecular mediators as promising targets for innovative combination therapies. This mechanistic understanding could enable novel approaches for mitigating both metabolic dysregulation and end-organ damage in diabetes management.

25 September 2025 in Life Sciences
Verified
Journal Article
Open access
XLXiaoya Li
Xiaoya Li
SWShengchen Wang
Shengchen Wang
XMXiaoshuang Mao
Xiaoshuang Mao
MFMeirong Fang
Meirong Fang
XLXingyu Liu
Xingyu Liu
WJWen Jin
Wen Jin
Although the molecular mechanisms underlying dysregulation in adipocyte biological processes and lipid metabolism during obesity have been extensively studied, the limited therapeutic strategies developed thus far suggest that additional critical mechanisms influence obesity progression. Initially identified as a key mediator of environmental pollutant toxicity, the aryl hydrocarbon receptor (AhR) has garnered widespread attention in cancer and immune diseases due to its immunomodulatory functions. Recent studies have also revealed its involvement in metabolic disorders such as obesity. Notably, similar to findings in other diseases, AhR exerts complex and context-dependent roles in adipocyte biology and lipid metabolism during obesity. Based on a comprehensive review of the AhR signaling pathway, this manuscript systematically examines the roles of AhR in adipocyte differentiation, lipid metabolism, as well as thermogenesis in brown adipocytes. The objective is to elucidate the pathophysiological contributions of AhR to obesity development and progression, thereby establishing a theoretical foundation for mechanistic investigations and therapeutic interventions targeting obesity.

22 October 2025 in European Journal of Pharmacology
Verified
Journal Article
Closed access
XLXiaoya Li
Xiaoya Li
KCKangjian Chen
Kangjian Chen
XLXingyu Liu
Xingyu Liu
SWShengchen Wang
Shengchen Wang
JMJingjie Ma
Jingjie Ma
WJWen Jin
Wen Jin

15 May 2026 in Phytomedicine
Verified
Journal Article
Closed access
XLXiaoya Li
Xiaoya Li
XLXingyu Liu
Xingyu Liu
QYQinbin Ye
Qinbin Ye
SWShengchen Wang
Shengchen Wang
XXXiaoyu Xi
Xiaoyu Xi
CXCheng Xiao
Cheng Xiao